findmyKOL
Clinical trialNCT06996652Not, yet, recruitingPhase 2Interventional

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

SponsorYale UniversityEnrollment108REM Sleep Behavior Disorder
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Montreal Neurological Institute-Hospital at Mcgill University

    Montreal, Quebec, Canada

    Anne-Louise Lafontaine, MDMassimo Pandolfo, MDRonald B Postuma, MD
United States
  • Cedars Sinai Medical Center

    Los Angeles, California, United States

    Camille Malatt, MDEcho E Tan, MDElliot Hogg, MDMichele Tagliati, MDYvette Bordelon, MD, PhD
  • University of Colorado Anschutz

    Aurora, Colorado, United States

    Alexander Baumgartner, MDAmy Amara, MD, PhDJeanne Feuerstein, MD
  • Yale Medicine

    North Haven, Connecticut, United States

    Hae-Young Hawong, DO, PhDVeronica Santini, MD, MA
  • Parkinson'S Disease & Movement Disorders Center of Boca Raton

    Boca Raton, Florida, United States

    Jonathan Isaacson, MDRichard Dewey III, MDSagari Bette, MDStuart Isaacson, MD
  • Emory University School of Medicine

    Atlanta, Georgia, United States

    Kendall Nichols, MDLynne Marie Trotti, MD, MSc
  • Johns Hopkins University

    Baltimore, Maryland, United States

    Emile Moukheiber, MDKelly Mills, MD
  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

    Lan Luo, MD, MSMonica Makhija, MD
  • Massachusetts General Hospital

    Boston, Massachusetts, United States

    Aleksandar Videnovic, MD, MSc
  • University of Michigan

    Ann Arbor, Michigan, United States

    Kara Wyant, MDKelvin Chou, MD
  • University of Minnesota

    Minneapolis, Minnesota, United States

    Michael Howell, MD
  • Washington University

    St Louis, Missouri, United States

    Joel S. Perlmutter, MDScott Norris, MD
  • Cleveland Clinic Lou Ruvo Center for Brain Health - Las Vegas

    Las Vegas, Nevada, United States

    Zoltan Mari, MD
  • Dartmouth Hitchcock Medical Center

    Lebanon, New Hampshire, United States

    Glen Greenough, MDMarc Seltzer, MDMary Feldman, DOStephen Lee, MD, PhD
  • Weill Medical College of Cornell University

    New York, New York, United States

    Andrea Yoo, MDHarini Sarva, MDMoath Hamed, MDNatalie Hellmers, NP
  • Oregon Health & Science University

    Portland, Oregon, United States

    Delaram Safarpour, MDJoseph Quinn, MDMatthew Brodsky, MD
  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

    Gavin Villacorta, CRNPNabila Dahodwala, MD, MS
  • Medical University of South Carolina

    Charleston, South Carolina, United States

    Christine Cooper, MDChrstine Dziwis, MD
  • University of Texas Houston Medical Center

    Houston, Texas, United States

    Chiamaka Onuigbo, MDEmily Tharp, MDMya C Schiess, MDSudha S Tallavajhula, MD
  • University of Texas Health Science Center- San Antonio

    San Antonio, Texas, United States

    Cynthia Cornejo, PA-COkeanis Vaou, MD

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Jun 2026
Primary completion
1 Aug 2029
Completion
1 Aug 2029
Last update posted
30 Jun 2026
Registered enrollment
108
Registry id
NCT06996652

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.